London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Results after the Implantation of the new modified Lentis M plus toric X

Poster Details

First Author: M.Rau GERMANY

Co Author(s):                  

Abstract Details

Purpose:

To evaluate the optical, functional outcomes, contrast sensitivity,patients satisfaction after Implantation of multifocal Lentis M plus toric X

Setting:

Augenklinik Cham, Germany

Methods:

In prospective case studies we implanted Lentis M plus toric X in 40 eyes of 20 patients from July 2013 to July 2014. We evaluated post-operative refraction, uncorrected (UCVA) and best corrected (BCVA) distance, intermediate and near visual acuity, reading speed using Radner Charts and contrast sensitivity three months after implantation. The quality of vision, glare, halos, the need to wear glasses and the personal satisfaction of the patients was assessed with a validated questionnaire.

Results:

Three month after the implantation the mean BCVA for distance was 0,82 for Lentis M plus toric X with the mean correction +0,25 D. The mean UCVA for distance was 0,82, for intermediate vision 0,72 and for near vision 0,85. 96% of the patients were completely independent from glases. Only 5% of the patients were unsatisfied after the Implantation of Lentis M plus toric X because of glare and halos during night driving.

Conclusions:

The IOL LentisĀ® Mplus toric X IOL provides good visual acuity for distance, intermediate and near. As a result of the improved near vision with this new lens none of the patients needed the glasses for reading of small print.

Financial Disclosure:

One or more of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to Poster listing